Allergy Therapeutics (Allergy Therapeutics) Accounts Payable & Accrued Expense

: $25.43 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

Allergy Therapeutics's quarterly accounts payable & accrued expense declined from Dec. 2022 ($17.42 Mil) to Jun. 2023 ($10.90 Mil) but then increased from Jun. 2023 ($10.90 Mil) to Dec. 2023 ($25.43 Mil).

Allergy Therapeutics's annual accounts payable & accrued expense increased from Jun. 2021 ($9.36 Mil) to Jun. 2022 ($10.58 Mil) and increased from Jun. 2022 ($10.58 Mil) to Jun. 2023 ($10.90 Mil).

Allergy Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Allergy Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

7.79

8.42

9.36

10.58

10.90

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															19.87	10.58	17.42	10.90	25.43

Allergy Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Allergy Therapeutics (Allergy Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (OTCPK:AGYTF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

AGY:UK HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.